Skip to main content

Pfizer Business Innovation Segment revenue

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026 · Market value $164.8B

Business Innovation Segment revenue at Pfizer came to $300.0M for the quarter to 27 Sep 2026, down 12.8% from a year earlier.

As Pfizer reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$383.0MDec 2023$275.0MMar 2024$292.0MJun 2024$310.0MSep 2024$350.0MDec 2024$274.0MMar 2025$348.0MJun 2025$344.0MSep 2025$414.0MDec 2025$290.0MMar 2026$373.0MJun 2026$300.0MSep 2026
Pfizer Business Innovation Segment revenue, every reported period
Period endingBusiness Innovation Segment revenueChange on a yearFiled
27 Sep 2026$300.0Mdown 12.8%3 Nov 2026
28 Jun 2026$373.0Mup 7.2%4 Aug 2026
29 Mar 2026$290.0Mup 5.8%5 May 2026
31 Dec 2025$414.0Mup 18.3%26 Feb 2026
28 Sep 2025$344.0Mup 11.0%4 Nov 2025
29 Jun 2025$348.0Mup 19.2%5 Aug 2025
30 Mar 2025$274.0Mdown 0.4%5 May 2025
31 Dec 2024$350.0Mdown 8.6%27 Feb 2025
29 Sep 2024$310.0Mup 2.3%4 Nov 2024
30 Jun 2024$292.0Mdown 7.9%5 Aug 2024
31 Mar 2024$275.0Mdown 12.1%8 May 2024
31 Dec 2023$383.0M—22 Feb 2024
1 Oct 2023$303.0M—4 Nov 2024
2 Jul 2023$317.0M—5 Aug 2024
2 Apr 2023$313.0M—8 May 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Pfizer: Product revenue · Royalty revenue · Pfizer CentreOne revenue · Biopharma revenue · United States revenue · International Developed Markets revenue · International Emerging Markets revenue · financial statements

Every KPI and segment of PFE, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.